|
|
|
|
| Boost your gene therapy production with the VirusExpress® AAV Platform! Our transfection-based solution ensures high-yield, scalable adeno-associated virus (AAV) manufacturing with streamlined processes. Designed for efficiency, VirusExpress® AAV Platform reduces production costs while maintaining consistency and compliance with regulatory standards. Elevate your bioprocessing capabilities and accelerate your path to clinical success with our innovative solutions. Learn more. |
|
|
|
|
With additional cell therapy approvals on the horizon, diverse products and platforms are needed to help ensure safety and efficacy in manufacturing, increase speed to market, and decrease overall CoGS. |
|
|
|
|
| Managing Cash Flow And Financial Vulnerability For CGT | White Paper | Cardinal Health | Pharmaceutical companies that are able to mitigate financial risk for CGT providers and ease cash flow burdens will stand out as preferred partners in an increasingly competitive industry. |
|
|
|
| Reliability And The Future Of Cell And Gene Therapies | Q&A | Andelyn Biosciences | Reliability issues continue to persist in GMP manufacturing for the cell and gene space. Learn how companies are focusing on reliability and predictability to further advance this innovative therapy. |
|
|
| Qualification Considerations For A “Factory-In-A-Box” | White Paper | By Moria Feighery-Ross and Wai Wong, Pharmatech Associates - A USP Company | The cell therapy market is rapidly expanding into a multibillion-dollar industry, but its production is cost-prohibitive. Enter the "factory-in-a-box," which can be a game-changer. |
|
|
| Supporting Cell And Gene Therapy Manufacturing | Infographic | SGS | Ensuring the safety and efficacy of cell and gene therapy treatments necessitates rigorous quality control. See how an outsourcing partner can help you deliver safe, efficacious therapies to patients. |
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
